Baxter International Inc. (BAX)

NYSE: BAX · IEX Real-Time Price · USD
42.00
-0.55 (-1.29%)
Feb 26, 2024, 4:00 PM EST - Market closed
-1.29%
Market Cap 21.33B
Revenue (ttm) 14.81B
Net Income (ttm) 2.66B
Shares Out 507.83M
EPS (ttm) 5.25
PE Ratio 8.00
Forward PE 14.38
Dividend $1.16 (2.76%)
Ex-Dividend Date Feb 29, 2024
Volume 2,346,230
Open 42.44
Previous Close 42.55
Day's Range 41.81 - 42.54
52-Week Range 31.01 - 50.21
Beta 0.61
Analysts Buy
Price Target 47.45 (+12.98%)
Earnings Date Feb 8, 2024

About BAX

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technol... [Read more]

Sector Healthcare
Founded 1931
Employees 60,000
Stock Exchange NYSE
Ticker Symbol BAX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for BAX stock is "Buy." The 12-month stock price forecast is $47.45, which is an increase of 12.98% from the latest price.

Price Target
$47.45
(12.98% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation

Baxter to act as exclusive partner to Spectral for 10 years following PMX approval by U.S. FDA Baxter to act as exclusive partner to Spectral for 10 years following PMX approval by U.S. FDA

5 days ago - GlobeNewsWire

Baxter To Spin-Off Vantive (Kidney Care Unit) In July 2024

On February 8, 2024, Baxter International BAX Inc. (NYSE: BAX, $39.64, Market Capitalization: $20.1 billion), a global medtech leader, reported steady 4Q23 results, with a mild beat vs consensus on re...

11 days ago - Forbes

Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients

TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, t...

12 days ago - GlobeNewsWire

Baxter Declares Quarterly Dividend

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share o...

14 days ago - Business Wire

Medical device maker Baxter beats sales and profit estimates on strong demand

Baxter International beat Wall Street expectations for fourth-quarter sales and profit on Thursday on strong demand for its medical devices and improvements in the supply chain environment.

19 days ago - Reuters

Baxter Reports Fourth-Quarter and Full-Year 2023 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2023, and provided its finan...

19 days ago - Business Wire

Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2023 financial results on Thursday, February ...

7 weeks ago - Business Wire

Spectral Medical Provides Tigris Trial Update

TORONTO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, t...

2 months ago - GlobeNewsWire

Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous (IV)...

2 months ago - Business Wire

Baxter to Present at 42nd Annual J.P. Morgan Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. José (Joe...

2 months ago - Business Wire

Strategist: Buy Baxter stock, skip Eli Lilly stock

Novo Nordisk (NVO) was named Yahoo Finance's Company of the Year thanks to the success of its diabetes and weight loss drugs, Ozempic and Wegovy. But there are other ways you can play the GLP-1 hype.

Other symbols: LLY
2 months ago - Yahoo Finance

Baxter Publishes Task Force on Climate-Related Financial Disclosures (TCFD) Report and Is Named to Dow Jones Sustainability Index North America

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its first report aligned with the Task Force on Climate-related Financial Disclosures (...

2 months ago - Business Wire

The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt

DEERFIELD, Ill. & NEW YORK--(BUSINESS WIRE)--The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF, today announced a partnership to improve ac...

3 months ago - Business Wire

Baxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, announced today new data indicating Baxter's Sharesource remote patie...

4 months ago - Business Wire

Baxter International beats Q3 profit estimates on strong demand for medical devices

Baxter International on Thursday beat Wall Street expectations for third-quarter revenue and profit, as a recovery in surgical procedure volumes after the pandemic helped drive the demand for its medi...

4 months ago - Reuters

Baxter Reports Third-Quarter 2023 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2023. “Baxter continues to successfully execute upon th...

4 months ago - Business Wire

The Value Deepens for Medtech Stocks: Reversal Imminent

Results from Johnson & Johnson NYSE: JNJ and Abbott Laboratories NYSE: ABT foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength...

Other symbols: ABTISRGJNJMDTSYK
4 months ago - MarketBeat

6 Medical Device Stocks Primed to Bounce Back

Some investors have worried that new weight-loss drugs could undermine demand for some medical devices.

Other symbols: DXCMPENPODDRMDZBH
4 months ago - Barrons

BAXTER ALERT: Bragar Eagel & Squire, P.C. is Investigating Baxter International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Baxter International, Inc. (NYSE: BAX) on be...

4 months ago - Business Wire

What other industries could weight loss drugs disrupt?

Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.

4 months ago - CNBC Television

Is the euphoria around these drugs really warranted?

Dr. Kavita Patel, joins the ‘Fast Money' traders to discuss the obesity drug euphoria.

Other symbols: DVA
4 months ago - CNBC Television

Dialysis company shares plunge after Ozempic trial success vs. kidney trouble

The trial success of Novo Nordisk's hit drug against kidney failure sent shares of a German kidney dialysis services firm plummeting on Wednesday.

Other symbols: FMSISRGBSX
4 months ago - Market Watch

Baxter Appoints Joel Grade Chief Financial Officer

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Joel Grade as executive vice president and chief financial officer (CF...

5 months ago - Business Wire

Advent International and Warburg Pincus Complete Acquisition of Baxter's BioPharma Solutions Business

BOSTON & NEW YORK--(BUSINESS WIRE)--Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, toda...

5 months ago - Business Wire

Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2023 financial results on Thursday, November 2...

5 months ago - Business Wire